Skip to main content

Sequenom Sells Two MassArray Systems Each to Broad Institute, Sanger Institute

NEW YORK, Sept. 21 (GenomeWeb News) - Sequenom has sold two of its MassArray Compact genotyping systems each to the Broad Institute of MIT and Harvard and to the Wellcome Trust Sanger Institute, the company said today.

 

The sales resulted from positive beta test results of Sequenom's iPlex assays at the two institutions for various fine mapping projects, according to the company.

 

Researchers at the Broad used the iPlex assays for fine mapping and biomarker validation of an international consortium study on type 2 diabetes. At the Sanger Institute, scientists used the iPlex approach for follow-up studies to genome scans.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.